These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3327044)

  • 1. [Presence of binding sites for steroid hormones in urothelial tumors].
    Zaroli A; Stagni F; Lampertico P
    Pathologica; 1987; 79(1059-1060):205-15. PubMed ID: 3327044
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of estrogen receptors and progesterone receptors in transitional cell carcinoma of bladder.
    Shan Y; Li L; Yan C; Yin F
    Chin Med J (Engl); 1998 Feb; 111(2):191-2. PubMed ID: 10374388
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lectin receptors in transitional cell tumors of the bladder].
    Dmitruk IM; Zerbino DD; Lutsik AD
    Vopr Onkol; 1987; 33(4):60-5. PubMed ID: 3590660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone receptors in localized and advanced transitional cell carcinoma of urinary tract in humans.
    Noronha RF; Rao BR
    Urology; 1986 Nov; 28(5):401-3. PubMed ID: 3787903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical leiomyoma of the urinary bladder--a rare tumor occurring in a young female with concurrent breast carcinoma--an influence of sex steroid hormone?
    Huang HY; Chen WJ; Sung MT; Huang CC
    Scand J Urol Nephrol; 2002; 36(3):231-3. PubMed ID: 12201943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
    Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
    Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterisation of transitional cell tumors of the urinary bladder by cytophotometric investigations and by studies of the nuclear structure (author's transl)].
    Lederer B; Mikuz G; zur Nedden G; Gütter W
    Verh Dtsch Ges Pathol; 1973; 57():200-3. PubMed ID: 4142175
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lectins in the urothelium and its tumors: staining sites, types and distribution].
    Sánchez Fernández de Sevilla MD; Pérez Bacete M; Morell Quadreny L; Chuán Nuez P; Martorell Cebollada MA
    Arch Esp Urol; 1988 Oct; 41(8):561-7. PubMed ID: 3248008
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
    Flamm J
    Z Urol Nephrol; 1987 Nov; 80(11):641-6. PubMed ID: 3439374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random biopsies and recurrence rates in bladder tumors.
    Ruacan S; Ozen H; Tuncer I; Akdaş A
    Turk J Pediatr; 1984; 26(1-4):227-32. PubMed ID: 6537076
    [No Abstract]   [Full Text] [Related]  

  • 15. Sex-steroid hormone receptors in human medullary thyroid carcinoma.
    Colomer A; Martínez-Mas JV; Matias-Guiu X; Llorens A; Cabezas R; Prat J; Garcia-Ameijeiras A
    Mod Pathol; 1996 Jan; 9(1):68-72. PubMed ID: 8821960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
    Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J
    Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.